• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Early predictors and screening tool developing for severe patients with COVID-19

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Oct 7;21(1):1040.
doi: 10.1186/s12879-021-06662-y.
Early predictors and screening tool developing for severe patients with COVID-19


Le Fang[SUP] #[/SUP][SUP] 1 [/SUP], Huashan Xie[SUP] #[/SUP][SUP] 2 [/SUP], Lingyun Liu[SUP] #[/SUP][SUP] 2 [/SUP], Shijun Lu[SUP] 3 [/SUP], Fangfang Lv[SUP] 4 [/SUP], Jiancang Zhou[SUP] 4 [/SUP], Yue Xu[SUP] 1 [/SUP], Huiqing Ge[SUP] 4 [/SUP], Min Yu[SUP] 5 [/SUP], Limin Liu[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a declared global pandemic, causing a lot of death. How to quickly screen risk population for severe patients is essential for decreasing the mortality. Many of the predictors might not be available in all hospitals, so it is necessary to develop a simpler screening tool with predictors which can be easily obtained for wide wise.
Methods: This retrospective study included all the 813 confirmed cases diagnosed with COVID-19 before March 2nd, 2020 in a city of Hubei Province in China. Data of the COVID-19 patients including clinical and epidemiological features were collected through Chinese Disease Control and Prevention Information System. Predictors were selected by logistic regression, and then categorized to four different level risk factors. A screening tool for severe patient with COVID-19 was developed and tested by ROC curve.
Results: Seven early predictors for severe patients with COVID-19 were selected, including chronic kidney disease (OR 14.7), age above 60 (OR 5.6), lymphocyte count less than < 0.8 × 10[SUP]9[/SUP] per L (OR 2.5), Neutrophil to Lymphocyte Ratio larger than 4.7 (OR 2.2), high fever with temperature ≥ 38.5℃ (OR 2.2), male (OR 2.2), cardiovascular related diseases (OR 2.0). The Area Under the ROC Curve of the screening tool developed by above seven predictors was 0.798 (95% CI 0.747-0.849), and its best cut-off value is > 4.5, with sensitivity 72.0% and specificity 75.3%.
Conclusions: This newly developed screening tool can be a good choice for early prediction and alert for severe case especially in the condition of overload health service.

Keywords: Coronavirus disease 2019; Predictor; Screening; Severe patient.
 
Back
Top Bottom